{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:55:51Z","timestamp":1790553351108,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12859-8","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:45:11Z","timestamp":1790505911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of NAT2 coding variants, combined genotypes, and haplotypes in prostate cancer susceptibility: a case-control study in an Iraqi Arab population"],"prefix":"10.1007","volume":"53","author":[{"given":"Murtadha A.","family":"Tarish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam K.","family":"Kudhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"12859_CR1","doi-asserted-by":"crossref","unstructured":"Sheweita S, Tilmisany A (2003) Cancer and Phase II Drug-Metabolizing Enzymes. Curr Drug Metab [Internet] 4(1):45\u201358. Available from: http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1389-2002&volume=4&issue=1&spage=45","DOI":"10.2174\/1389200033336919"},{"key":"12859_CR2","doi-asserted-by":"publisher","unstructured":"Jancova P, Anzenbacher P, Anzenbacherova E, PHASE II DRUG METABOLIZING ENZYMES (2010). Biomed Pap [Internet] 154(2):103\u201316. Available from: http:\/\/biomed.papers.upol.cz\/doi\/https:\/\/doi.org\/10.5507\/bp.2010.017.html","DOI":"10.5507\/bp.2010.017.html"},{"key":"12859_CR3","doi-asserted-by":"crossref","unstructured":"Vineis P (2002) The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology [Internet] 181\u2013182:457\u201362. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X0200450X","DOI":"10.1016\/S0300-483X(02)00450-X"},{"key":"12859_CR4","doi-asserted-by":"crossref","unstructured":"Martinez-Gonzalez LJ, Ant\u00fanez-Rodr\u00edguez A, Vazquez-Alonso F, Hernandez AF, Alvarez-Cubero MJ (2020) Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer. Sci Total Environ [Internet] 730:138314. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0048969720318271","DOI":"10.1016\/j.scitotenv.2020.138314"},{"key":"12859_CR5","doi-asserted-by":"crossref","unstructured":"Hein DW (2002) Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res - Fundam Mol Mech Mutagen [Internet] 506\u2013507:65\u201377. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510702001537","DOI":"10.1016\/S0027-5107(02)00153-7"},{"key":"12859_CR6","doi-asserted-by":"publisher","unstructured":"Sim E, Abuhammad A, Ryan A (2014) Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. Br J Pharmacol [Internet] 171(11):2705\u201325. Available from: https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/bph.12598","DOI":"10.1111\/bph.12598"},{"key":"12859_CR7","doi-asserted-by":"publisher","unstructured":"Turesky RJ, Le Marchand L (2011) Metabolism and Biomarkers of Heterocyclic Aromatic Amines in Molecular Epidemiology Studies: Lessons Learned from Aromatic Amines. Chem Res Toxicol [Internet] 24(8):1169\u2013214. Available from: https:\/\/pubs.acs.org\/doi\/https:\/\/doi.org\/10.1021\/tx200135s","DOI":"10.1021\/tx200135s"},{"issue":"3","key":"12859_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1081\/dmr-120005665","volume":"34","author":"RJ Turesky","year":"2002","unstructured":"Turesky RJ (2002) Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. Drug Metab Rev 34(3):625\u2013650. https:\/\/doi.org\/10.1081\/dmr-120005665","journal-title":"Drug Metab Rev"},{"key":"12859_CR9","doi-asserted-by":"crossref","unstructured":"Sim E, Walters K, Boukouvala S (2008) Arylamine N-acetyltransferases: From Structure to Function. Drug Metab Rev [Internet] 40(3):479\u2013510. Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03602530802186603","DOI":"10.1080\/03602530802186603"},{"key":"12859_CR10","doi-asserted-by":"crossref","unstructured":"King CM, Land SJ, Jones RF, Debiec-Rychter M, Lee MS, Wang CY (1997) Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutat Res - Fundam Mol Mech Mutagen [Internet] 376(1\u20132):123\u20138. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510797000341","DOI":"10.1016\/S0027-5107(97)00034-1"},{"key":"12859_CR11","doi-asserted-by":"crossref","unstructured":"Boukouvala S, Sim E (2005) Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts. Basic Clin Pharmacol Toxicol [Internet] 96(5):343\u201351. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15853926","DOI":"10.1111\/j.1742-7843.2005.pto_02.x"},{"key":"12859_CR12","doi-asserted-by":"publisher","unstructured":"Papanikolaou G, Poloni ES, Ag\u00fandez JAG, Teixeira RLF, Boone EC, Rezende Santos A et al (2026) PharmVar GeneFocus: NAT2\u2014Genetic Variation and Updated Nomenclature. Clin Pharmacol Ther [Internet] 119(4):859\u201371. Available from: https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/cpt.70168","DOI":"10.1002\/cpt.70168"},{"key":"12859_CR13","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Virgen JE, Pi\u00f1a-Pozas M, Hern\u00e1ndez-Tob\u00edas EA, Taja-Chayeb L, L\u00f3pez-Gonz\u00e1lez MdeL, Meraz-R\u00edos MA et al (2023) NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review. PLoS One [Internet] 18(4):e0283726. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37023111","DOI":"10.1371\/journal.pone.0283726"},{"key":"12859_CR14","doi-asserted-by":"publisher","unstructured":"Mortensen HM, Froment A, Lema G, Bodo JM, Ibrahim M, Nyambo TB et al (2011) Characterization of Genetic Variation and Natural Selection at the Arylamine N -Acetyltransferase Genes in Global Human Populations. Pharmacogenomics [Internet] 12(11):1545\u201358. Available from: https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.2217\/pgs.11.88","DOI":"10.2217\/pgs.11.88"},{"key":"12859_CR15","doi-asserted-by":"crossref","unstructured":"Hein DW, Doll MA (2012) Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Pharmacogenomics [Internet] 13(1):31\u201341. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22092036","DOI":"10.2217\/pgs.11.122"},{"key":"12859_CR16","doi-asserted-by":"crossref","unstructured":"Sabbagh A, Darlu P (2006) SNP selection at the NAT2 locus for an accurate prediction of the acetylation phenotype. Genet Med [Internet] 8(2):76\u201385. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16481889","DOI":"10.1097\/01.gim.0000200951.54346.d6"},{"key":"12859_CR17","doi-asserted-by":"crossref","unstructured":"Husain A, Zhang X, Doll MA, States JC, Barker DF, Hein DW (2007) Identification of N-Acetyltransferase 2 (NAT2) Transcription Start Sites and Quantitation of NAT2-Specific mRNA in Human Tissues. Drug Metab Dispos [Internet] 35(5):721\u20137. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562401287X","DOI":"10.1124\/dmd.106.014621"},{"key":"12859_CR18","doi-asserted-by":"crossref","unstructured":"Sabbagh A, Darlu P (2005) Inferring haplotypes at the NAT2 locus: the computational approach. BMC Genet [Internet] 6:30. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15932650","DOI":"10.1186\/1471-2156-6-30"},{"key":"12859_CR19","doi-asserted-by":"crossref","unstructured":"Hein DW (2006) N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene [Internet] 25(11):1649\u201358. Available from: https:\/\/www.nature.com\/articles\/1209374","DOI":"10.1038\/sj.onc.1209374"},{"key":"12859_CR20","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW et al (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet [Internet] 366(9486):649\u201359. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673605671371","DOI":"10.1016\/S0140-6736(05)67137-1"},{"key":"12859_CR21","doi-asserted-by":"crossref","unstructured":"Le Marchand L, Hankin JH, Pierce LM, Sinha R, Nerurkar PV, Franke AA et al (2002) Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat Res - Fundam Mol Mech Mutagen [Internet] 506\u2013507:205\u201314. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510702001677","DOI":"10.1016\/S0027-5107(02)00167-7"},{"key":"12859_CR22","doi-asserted-by":"crossref","unstructured":"Huang YS, Chern HD, Wu JC, Chao Y, Huang YH, Chang FY et al (2003) Polymorphism of The N -Acetyltransferase 2 Gene, Red Meat Intake, and The Susceptibility of Hepatocellular Carcinoma. Am J Gastroenterol [Internet] 98(6):1417\u201322. Available from: https:\/\/journals.lww.com\/00000434-200306000-00036","DOI":"10.1111\/j.1572-0241.2003.07452.x"},{"key":"12859_CR23","doi-asserted-by":"publisher","unstructured":"Vil\u010dkov\u00e1 M, Jure\u010dekov\u00e1 J, Dobrota D, Habalov\u00e1 V, Klim\u010d\u00e1kov\u00e1 L, Waczul\u00edkov\u00e1 I et al (2014) Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population. Med Oncol [Internet] 31(6):987. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12032-014-0987-3","DOI":"10.1007\/s12032-014-0987-3"},{"key":"12859_CR24","doi-asserted-by":"crossref","unstructured":"Koutros S, Berndt SI, Sinha R, Ma X, Chatterjee N, Alavanja MCR et al (2009) Xenobiotic Metabolizing Gene Variants, Dietary Heterocyclic Amine Intake, and Risk of Prostate Cancer. Cancer Res [Internet] 69(5):1877\u201384. Available from: https:\/\/aacrjournals.org\/cancerres\/article\/69\/5\/1877\/552935\/Xenobiotic-Metabolizing-Gene-Variants-Dietary","DOI":"10.1158\/0008-5472.CAN-08-2447"},{"key":"12859_CR25","doi-asserted-by":"publisher","unstructured":"Gong C, Hu X, Gao Y, Cao Y, Gao F, Mo Z (2011) A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review. Med Oncol [Internet] 28(1):365\u201376. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12032-010-9423-5","DOI":"10.1007\/s12032-010-9423-5"},{"key":"12859_CR26","doi-asserted-by":"crossref","unstructured":"Wang F, Qin Z, Si S, Tang J, Xu L, Xu H et al (2017) Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysis. Oncotarget [Internet] 8(34):57440\u201350. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28915684","DOI":"10.18632\/oncotarget.19023"},{"key":"12859_CR27","doi-asserted-by":"crossref","unstructured":"Sharma S, Cao X, Wilkens LR, Yamamoto J, Lum-Jones A, Henderson BE et al (2010) Well-Done Meat Consumption, NAT1 and NAT2 Acetylator Genotypes and Prostate Cancer Risk: The Multiethnic Cohort study. Cancer Epidemiol Biomarkers Prev [Internet] 19(7):1866\u201370. Available from: https:\/\/aacrjournals.org\/cebp\/article\/19\/7\/1866\/68529\/Well-Done-Meat-Consumption-NAT1-and-NAT2","DOI":"10.1158\/1055-9965.EPI-10-0231"},{"key":"12859_CR28","doi-asserted-by":"crossref","unstructured":"Nesa A, Mostafijur Rahman M, Tahminur Rahman M, Kabir Y (2023) Association of NAT2, GSTT1, and GSTM1 gene polymorphisms withprostate cancer risk in Bangladeshi population. Gene [Internet] 868:147368. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111923002093","DOI":"10.1016\/j.gene.2023.147368"},{"key":"12859_CR29","doi-asserted-by":"publisher","unstructured":"Hamasaki T, Inatomi H, Katoh T, Aono H, Ikuyama T, Muratani T et al (2003) N -acetyltransferase\u20102 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. Int J Urol [Internet] 10(3):167\u201373. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1046\/j.1442-2042.2003.00586.x","DOI":"10.1046\/j.1442-2042.2003.00586.x"},{"key":"12859_CR30","doi-asserted-by":"crossref","unstructured":"Chakravarty D, Solit DB (2021) Clinical cancer genomic profiling. Nat Rev Genet [Internet] 22(8):483\u2013501. Available from: https:\/\/www.nature.com\/articles\/s41576-021-00338-8","DOI":"10.1038\/s41576-021-00338-8"},{"key":"12859_CR31","unstructured":"Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH et al (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev [Internet] 9(1):29\u201342. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10667461"},{"key":"12859_CR32","doi-asserted-by":"publisher","unstructured":"Sabbagh A, Langaney A, Darlu P, G\u00e9rard N, Krishnamoorthy R, Poloni ES (2008) Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history. BMC Genet [Internet] 9(1):21. Available from: https:\/\/bmcgenet.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/1471-2156-9-21","DOI":"10.1186\/1471-2156-9-21"},{"key":"12859_CR33","doi-asserted-by":"publisher","unstructured":"Lawi ZK, Al-Shuhaib MBS, Amara I, Ben (2023) The rs1801280 SNP is associated with non-small cell lung carcinoma by exhibiting a highly deleterious effect on N-acetyltransferase 2. J Cancer Res Clin Oncol [Internet] 149(1):147\u201357. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00432-022-04332-3","DOI":"10.1007\/s00432-022-04332-3"},{"key":"12859_CR34","doi-asserted-by":"crossref","unstructured":"Malik MA, Upadhyay R, Modi DR, Zargar SA, Mittal B (2009) Association of NAT2 Gene Polymorphisms with Susceptibility to Esophageal and Gastric Cancers in the Kashmir Valley. Arch Med Res [Internet] 40(5):416\u201323. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440909001246","DOI":"10.1016\/j.arcmed.2009.06.009"},{"key":"12859_CR35","doi-asserted-by":"publisher","unstructured":"Selinski S, Blaszkewicz M, Ickstadt K, Hengstler JG, Golka K (2013) Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk. Arch Toxicol [Internet] 87(12):2129\u201339. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00204-013-1157-7","DOI":"10.1007\/s00204-013-1157-7"},{"key":"12859_CR36","doi-asserted-by":"crossref","unstructured":"Suarez-Kurtz G, Sortica VA, Vargens DD, Bruxel EM, Petz-Erler ML, Tsuneto LT et al (2012) Impact of population diversity on the prediction of 7-SNP NAT2 phenotypes using the tagSNP rs1495741 or paired SNPs. Pharmacogenet Genomics [Internet] 22(4):305\u20139. Available from: https:\/\/journals.lww.com\/01213011-201204000-00009","DOI":"10.1097\/FPC.0b013e3283519c7c"},{"key":"12859_CR37","doi-asserted-by":"publisher","unstructured":"Garnier-G\u00e9r\u00e9 P, Chikhi L (2013) Population Subdivision, Hardy\u2013Weinberg Equilibrium and the Wahlund Effect. In: Encyclopedia of Life Sciences [Internet]. Wiley; Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/9780470015902.a0005446.pub3","DOI":"10.1002\/9780470015902.a0005446.pub3"},{"key":"12859_CR38","unstructured":"Royo JL (2021) Hardy Weinberg Equilibrium Disturbances in Case-Control Studies Lead to Non-Conclusive Results. Cell J [Internet] 22(4):572\u20134. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32347052"},{"key":"12859_CR39","doi-asserted-by":"crossref","unstructured":"Salanti G, Amountza G, Ntzani EE, Ioannidis JPA (2005) Hardy\u2013Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet [Internet] 13(7):840\u20138. Available from: https:\/\/www.nature.com\/articles\/5201410","DOI":"10.1038\/sj.ejhg.5201410"},{"key":"12859_CR40","doi-asserted-by":"publisher","unstructured":"Al-Khatib SM, Ababneh O, Abushukair H, Abdo N, Al-Eitan LN (2023) The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study. Galli A, editor. PLoS One [Internet] 18(7):e0289014. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0289014","DOI":"10.1371\/journal.pone.0289014"},{"key":"12859_CR41","doi-asserted-by":"crossref","unstructured":"Zou Y, Dong S, Xu S, Gong Q, Chen J (2017) Genetic polymorphisms of NAT2 and risk of acute myeloid leukemia. Medicine (Baltimore) [Internet] 96(42):e7499. Available from: https:\/\/journals.lww.com\/00005792-201710200-00017","DOI":"10.1097\/MD.0000000000007499"},{"key":"12859_CR42","doi-asserted-by":"publisher","unstructured":"Tian F, Zhang Y, Ren Y, Shen L, Wu W, Zhou B (2014) N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males. Med Oncol [Internet] 31(8):90. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12032-014-0090-9","DOI":"10.1007\/s12032-014-0090-9"},{"key":"12859_CR43","doi-asserted-by":"crossref","unstructured":"Campayo M, Vi\u00f1olas N, Navarro A, Carcereny E, Casas F, Gel B et al (2011) Single Nucleotide Polymorphisms in Tobacco Metabolism and DNA Repair Genes and Prognosis in Resected Non-Small-Cell Lung Cancer. J Surg Res [Internet] 167(1):e5\u201312. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480411000047","DOI":"10.1016\/j.jss.2011.01.007"},{"key":"12859_CR44","doi-asserted-by":"crossref","unstructured":"Tian FS, Shen L, Ren YW, Zhang Y, Yin ZH, Zhou BS (2014) N-Acetyltransferase 2 Gene Polymorphisms are Associated with Susceptibility to Cancer: a Meta-analysis. Asian Pacific J Cancer Prev [Internet] 15(14):5621\u20136. Available from: http:\/\/koreascience.or.kr\/journal\/view.jsp?kj=POCPA9&py=2014&vnc=v15n14&sp=5621","DOI":"10.7314\/APJCP.2014.15.14.5621"},{"key":"12859_CR45","doi-asserted-by":"crossref","unstructured":"Hadziosmanovic O, Kulovac B, Valjevac A, Fajki\u0107 A, Uzar I, Adler G (2025) Influence of Glutathione S-transferase Mu 1 (GSTM1), Glutathione S-transferase Theta 1 (GSTT1), and N-acetyltransferase 2 (NAT2) Variants on Bladder Cancer Progression and Recurrence Rating: A Bosnian and Herzegovinian Case-Control Study. Cureus [Internet] Available from: https:\/\/www.cureus.com\/articles\/406410-influence-of-glutathione-s-transferase-mu-1-gstm1-glutathione-s-transferase-theta-1-gstt1-and-n-acetyltransferase-2-nat2-variants-on-bladder-cancer-progression-and-recurrence-rating-a-bosnian-and-herzegovinian-case-c","DOI":"10.7759\/cureus.91948"},{"key":"12859_CR46","unstructured":"Kabzi\u0144ski J, Gogolewska M, Nowakowski M, Kucharska E, Dziki \u0141, Mik M et al (2022) Polymorphism association of NIL1, NIL2 [sic], CYP1A1 xenobiotic metabolism genes and their expression with the risk of colorectal cancer in the Polish population. Pol Przegl Chir [Internet] 94(2):54\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35485310"},{"key":"12859_CR47","doi-asserted-by":"crossref","unstructured":"Balaji L, Krishna BS, L.V.K.S. B (2012) An unlikely role for the NAT2 genotypes and haplotypes in the oral cancer of south Indians. Arch Oral Biol [Internet] 57(5):513\u20138. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003996911003529","DOI":"10.1016\/j.archoralbio.2011.10.019"},{"key":"12859_CR48","doi-asserted-by":"publisher","unstructured":"Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T (2010) Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case\u2013control study in Thai women. Breast Cancer Res Treat [Internet] 123(3):885\u201393. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s10549-010-0804-4","DOI":"10.1007\/s10549-010-0804-4"},{"key":"12859_CR49","doi-asserted-by":"crossref","unstructured":"Koda M, Iwasaki M, Yamano Y, Lu X, Katoh T (2017) Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan. Environ Health Prev Med [Internet] 22(1):72. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29165164","DOI":"10.1186\/s12199-017-0681-0"},{"key":"12859_CR50","doi-asserted-by":"publisher","unstructured":"Lavender N, Hein W, Brock D, Creis G, Kidd R (2015) L. Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate Cancer. AIMS Med Sci [Internet] 2(4):271\u201394. Available from: http:\/\/www.aimspress.com\/article\/https:\/\/doi.org\/10.3934\/medsci.2015.4.271","DOI":"10.3934\/medsci.2015.4.271"},{"key":"12859_CR51","doi-asserted-by":"crossref","unstructured":"Bellamri M, Xiao S, Murugan P, Weight CJ, Turesky RJ (2018) Metabolic Activation of the Cooked Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine in Human Prostate. Toxicol Sci [Internet] 163(2):543\u201356. Available from: https:\/\/academic.oup.com\/toxsci\/article\/163\/2\/543\/4955276","DOI":"10.1093\/toxsci\/kfy060"},{"key":"12859_CR52","doi-asserted-by":"crossref","unstructured":"Patillon B, Luisi P, Poloni ES, Boukouvala S, Darlu P, Genin E et al (2014) A Homogenizing Process of Selection Has Maintained an Ultra-Slow Acetylation NAT2 Variant in Humans. Hum Biol [Internet] 86(3):185. Available from: https:\/\/muse.jhu.edu\/article\/577440","DOI":"10.13110\/humanbiology.86.3.0185"},{"key":"12859_CR53","doi-asserted-by":"publisher","unstructured":"Kasajova P, Holubekova V, Mendelova A, Lasabova Z, Zubor P, Kudela E et al (2016) Active cigarette smoking and the risk of breast cancer at the level of N-acetyltransferase 2 (NAT2) gene polymorphisms. Tumor Biol [Internet] 37(6):7929\u201337. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s13277-015-4685-3","DOI":"10.1007\/s13277-015-4685-3"},{"key":"12859_CR54","doi-asserted-by":"publisher","unstructured":"Cox DG, Dostal L, Hunter DJ, Le Marchand L, Hoover R, Ziegler RG et al (2011) N-Acetyltransferase 2 Polymorphisms, Tobacco Smoking, and Breast Cancer Risk in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol [Internet] 174(11):1316\u201322. Available from: https:\/\/academic.oup.com\/aje\/article-lookup\/doi\/https:\/\/doi.org\/10.1093\/aje\/kwr257","DOI":"10.1093\/aje\/kwr257"},{"key":"12859_CR55","doi-asserted-by":"crossref","unstructured":"Perini JA, Basta PC, Cardoso JV, Elias ABR, Suarez-Kurtz G (2024) Differential distribution of NAT2 polymorphisms and NAT2 acetylator phenotypes among indigenous populations of the Brazilian Amazon. Pharmacogenet Genomics [Internet] 34(9):269\u201374. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39259702","DOI":"10.1097\/FPC.0000000000000544"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12859-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:01:52Z","timestamp":1790550112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12859-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12859"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12859-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"18 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Scientific Committee of the Department of Laboratory Investigations (Approval No. LI0468) in September 2025.","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1644"}}